Lp-PLA2, Lipoprotein-Associated Phospholipase A2, Activity (PLAC)
Also known as: PLAC A
Use
Lp-PLA2 activity is used to evaluate atherosclerotic cardiovascular disease. It should be used in conjunction with clinical evaluation and patient risk assessment, providing additional information as an indicator of atherosclerotic cardiovascular disease. However, Lp-PLA2 activity does not replace traditional lipid testing or other conventional risk factors for cardiovascular disease.
Special Instructions
Ensure complete clot formation has taken place prior to centrifugation. Transfer 1 mL serum to an ARUP Standard Transport Tube. Minimum volume required is 0.2 mL. Samples that are visibly hemolyzed should be redrawn.
Limitations
This test should not be used as a standalone marker for cardiovascular risk assessment. The Lp-PLA2 activity assay needs to be interpreted together with clinical findings and other established risk indicators of cardiovascular disease.
FDA ApprovedNew York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 86951-1
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Serum Separator Tube (SST). Also acceptable: Plain Red. Ensure complete clot formation has taken place prior to centrifugation.
Storage Instructions
Refrigerated.
Causes for Rejection
Hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 2 week |
| Frozen | 18 months |